Dolby Laboratories (NYSE:DLB) Posts Quarterly Earnings Results, Beats Estimates By $0.29 EPS

Dolby Laboratories (NYSE:DLB) posted its quarterly earnings data on Tuesday. The electronics maker reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29, FiscalAI reports. The firm had revenue of $307.02 million during the quarter, compared to analysts’ expectations of $305.76 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter last year, the company posted $0.61 EPS. Dolby Laboratories updated its FY 2026 guidance to 4.190-4.340 EPS and its Q1 2026 guidance to 0.790-0.940 EPS.

Dolby Laboratories Stock Performance

Shares of DLB opened at $65.13 on Wednesday. Dolby Laboratories has a 1 year low of $64.02 and a 1 year high of $89.66. The stock has a market capitalization of $6.24 billion, a PE ratio of 23.86 and a beta of 0.97. The stock has a 50-day simple moving average of $68.93 and a 200-day simple moving average of $72.51.

Dolby Laboratories Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd will be paid a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, December 2nd. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio (DPR) is 48.35%.

Insider Activity at Dolby Laboratories

In related news, CEO Kevin J. Yeaman sold 25,000 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total value of $1,721,750.00. Following the completion of the transaction, the chief executive officer owned 114,725 shares in the company, valued at $7,901,110.75. The trade was a 17.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares in the company, valued at approximately $5,276,990.20. This represents a 9.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 57,000 shares of company stock worth $4,037,690. 38.39% of the stock is owned by corporate insiders.

Institutional Trading of Dolby Laboratories

A number of institutional investors have recently bought and sold shares of DLB. Advisory Services Network LLC purchased a new position in shares of Dolby Laboratories in the 3rd quarter valued at about $102,000. XTX Topco Ltd purchased a new stake in Dolby Laboratories during the third quarter worth approximately $741,000. Verition Fund Management LLC boosted its holdings in Dolby Laboratories by 172.4% in the third quarter. Verition Fund Management LLC now owns 35,409 shares of the electronics maker’s stock valued at $2,563,000 after purchasing an additional 22,409 shares in the last quarter. Qube Research & Technologies Ltd boosted its holdings in Dolby Laboratories by 5.4% in the third quarter. Qube Research & Technologies Ltd now owns 474,159 shares of the electronics maker’s stock valued at $34,315,000 after purchasing an additional 24,506 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV increased its stake in Dolby Laboratories by 217.8% in the third quarter. Mercer Global Advisors Inc. ADV now owns 14,567 shares of the electronics maker’s stock valued at $1,054,000 after purchasing an additional 9,984 shares during the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

DLB has been the subject of several research analyst reports. Robert W. Baird initiated coverage on Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 price target for the company. Barrington Research restated an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a report on Friday, September 12th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Thursday, November 13th. Rosenblatt Securities set a $85.00 price target on shares of Dolby Laboratories in a research report on Wednesday. Finally, Baird R W raised shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $93.25.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.